Work

Advanced HIV disease and epidemic control in sub-Saharan Africa

Year: 2025

Type: article

Abstract: Antiretroviral treatment (ART) scale-up under the treat-all strategy has been the cornerstone of the global response to the HIV epidemic since 2015. Despite the subsequent increase in HIV treatment global coverage, reductions in AIDS-related mortality have lagged, likely because of advanced HIV disease (AHD).1 AHD, defined as a CD4 count of less than 200 cells per mm3 or WHO stage of 3 or 4 in people living with HIV age 5 years or older,2 has affected a persistent 30% of those initiating ART in clinical programmes since 2015, despite the ART scale-up.

Source: The Lancet Global Health

DOI: 10.1016/s2214-109x(25)00020-8

Authors: Jessica E Justman, Maureen Syowai

Institutions: Columbia University, ICAP Global Health

Language: English

Topic: HIV/AIDS Research and Interventions

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $6,680